INSPIRE MEDICAL SYSTEMS, INC.

(INSP)
  Report
Real-time Estimate Cboe BZX  -  11:52 2022-07-06 am EDT
201.89 USD   +0.44%
08:30aInspire Medical Systems Obtains FDA Approval for Use of Inspire Therapy With Full-Body MRI
MT
08:01aInspire Medical Systems, Inc. Announces FDA Approval of Expanded, Full-Body MRI Compatibility with Inspire Therapy
AQ
06:42aInspire Medical Gets FDA Approval for Full-Body MRIs
DJ
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
06/29/2022 06/30/2022 07/01/2022 07/05/2022 07/06/2022 Date
187.79(c) 182.67(c) 189.15(c) 201.01(c) 200 Last
146 756 419 739 175 351 221 646 58 715 Volume
-0.32% -2.73% +3.55% +6.27% -0.50% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 341 M - -
Net income 2022 -58,5 M - -
Net cash position 2022 181 M - -
P/E ratio 2022 -95,2x
Yield 2022 -
Sales 2023 453 M - -
Net income 2023 -41,0 M - -
Net cash position 2023 171 M - -
P/E ratio 2023 -139x
Yield 2023 -
Capitalization 5 546 M 5 546 M -
EV / Sales 2022 15,7x
EV / Sales 2023 11,9x
Nbr of Employees 485
Free-Float 98,0%
More Financials
Company
Inspire Medical Systems, Inc. is a medical technology company. The Company is focused on the development and commercialization of invasive solutions for patients with obstructive sleep apnea (OSA). The obstructive sleep apnea device that treats the root cause of sleep apnea by working inside the body with the patient’s natural breathing process. The Company has developed a novel, closed-loop solution that... 
More about the company
Ratings of Inspire Medical Systems, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C
More Ratings
All news about INSPIRE MEDICAL SYSTEMS, INC.
08:30aInspire Medical Systems Obtains FDA Approval for Use of Inspire Therapy With Full-Body ..
MT
08:01aInspire Medical Systems, Inc. Announces FDA Approval of Expanded, Full-Body MRI Compati..
AQ
06:42aInspire Medical Gets FDA Approval for Full-Body MRIs
DJ
07/05Inspire Medical Systems, Inc. to Report Second Quarter 2022 Financial Results on August..
AQ
06/22INSPIRE MEDICAL SYSTEMS, INC. : Entry into a Material Definitive Agreement, Creation of a ..
AQ
06/16Stifel Nicolaus Adjusts Inspire Medical Systems Price Target to $225 From $300, Maintai..
MT
06/14TRANSCRIPT : Inspire Medical Systems, Inc. Presents at Goldman Sachs 43rd Annual Global He..
CI
06/10Truist Securities Adjusts Price Target on Inspire Medical Systems to $250 From $296, Ma..
MT
06/06Inspire Medical Systems, Inc. to Present at the Goldman Sachs 43rd Annual Global Healt..
AQ
05/25TRANSCRIPT : Inspire Medical Systems, Inc. Presents at UBS Global Healthcare Conference, M..
CI
05/25Inspire Medical Systems, Inc. Announces Events at SLEEP 2022, the 36th Annual Meeting ..
AQ
05/12EnsoData, Inc. announced that it has received $20 million in funding from a group of in..
CI
05/11TRANSCRIPT : Inspire Medical Systems, Inc. Presents at Bank of America 2022 Healthcare Con..
CI
05/11Inspire Medical Systems, Inc. to Present at the USB Global Healthcare Conference 2022
AQ
05/04INSPIRE MEDICAL SYSTEMS, INC. : Regulation FD Disclosure, Financial Statements and Exhibit..
AQ
More news
News in other languages on INSPIRE MEDICAL SYSTEMS, INC.
08:30aInspire Medical Systems obtient l'approbation de la FDA pour l'utilisation de la thérap..
05/03Earnings Flash (INSP) INSPIRE MEDICAL SYSTEMS affiche un chiffre d'affaires de 69,4 mil..
05/03Inspire Medical Systems, Inc. annonce ses résultats pour le premier trimestre clos le 3..
05/03Inspire Medical Systems, Inc. révise ses prévisions de revenus pour l'année 2022
04/06VENTE D'INITIÉS : Inspire Medical Systems
More news
Analyst Recommendations on INSPIRE MEDICAL SYSTEMS, INC.
More recommendations
Chart INSPIRE MEDICAL SYSTEMS, INC.
Duration : Period :
Inspire Medical Systems, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends INSPIRE MEDICAL SYSTEMS, INC.
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 10
Last Close Price 201,01 $
Average target price 266,11 $
Spread / Average Target 32,4%
EPS Revisions
Managers and Directors
Timothy P. Herbert President, Chief Executive Officer & Director
Richard John Buchholz Chief Financial Officer
Marilyn Carlson Nelson Chairman
Philip J. Ebeling Chief Operating Officer
Bryan K. Phillips Secretary, Chief Compliance Officer & Senior VP
Sector and Competitors
1st jan.Capi. (M$)
INSPIRE MEDICAL SYSTEMS, INC.-12.63%5 546
STRYKER CORPORATION-24.46%76 395
SMITH & NEPHEW PLC-12.64%11 721
AXONICS, INC.7.57%2 836
DOUBLE MEDICAL TECHNOLOGY INC.-22.94%2 399
GLAUKOS CORPORATION6.57%2 240